menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

The Future of Clinical Sequencing: Whole Genome vs Exome Applications in Clinical Care

close
The Future of Clinical Sequencing: Whole Genome vs Exome Applications in Clinical Care
RestartResume
Choose a format
Media formats available:
Details
Presenters
Comments
  • Overview

    When patients and clinicians alike consider genome sequencing, an attitude of "more is better" often predominates notions of what information to obtain. But new perspectives on the comparative value and contained costs of more refined exome sequencing have since emerged. Joining host Dr. Robert Green to discuss the benefits and drawbacks of respective clinical sequencing options is Dr. Richard Gibbs, Wofford Cain Chair and Professor of Molecular and Human Genetics, as well as Founder and Director of the Human Genome Sequencing Center at Baylor College of Medicine.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    When patients and clinicians alike consider genome sequencing, an attitude of "more is better" often predominates notions of what information to obtain. But new perspectives on the comparative value and contained costs of more refined exome sequencing have since emerged. Joining host Dr. Robert Green to discuss the benefits and drawbacks of respective clinical sequencing options is Dr. Richard Gibbs, Wofford Cain Chair and Professor of Molecular and Human Genetics, as well as Founder and Director of the Human Genome Sequencing Center at Baylor College of Medicine.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 2/19/20